Richard W. Mott, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 46,502 shares at $22.50 ($1.1M) on 2023-03-08, disclosed to the SEC on 2023-03-10.
Open-market sale of $1.1M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.50 | 25,000 | $563K | 52.0% |
| 2 | $24.00 | 20,000 | $480K | 44.4% |
| 3 | $26.00 | 1,502 | $39K | 3.6% |
| Total | $23.26 avg | 46,502 | $1.1M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-13 | $1.1M | — | Filing → |
| TMCI | SELL | 2023-04-10 | $105K | — | Filing → |
| TMCI | SELL | 2023-04-05 | $415K | — | Filing → |